Acumen Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAcumen Pharmaceuticals

Acumen Pharmaceuticals(ABOS)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Histone-arginine methyltransferase carm1

myeloid leukemia acute

,

myeloid leukemia

,

,

graft vs host disease

,

bronchiolitis obliterans syndrome

,

ovarian neoplasms

,

,

central nervous system neoplasms

,

germ cell and embryonal neoplasms

,

liver neoplasms

,

nervous system neoplasms

,

b-cell chronic lymphocytic leukemia

,

prolymphocytic leukemia

,

lymphoid leukemia

,

healthy volunteers/patients

,

drug-related side effects and adverse reactions

,

neoplasm metastasis

,

,

gastrointestinal neoplasms

,

,

non-small-cell lung carcinoma

,

,

,

squamous cell carcinoma of head and neck

,

colorectal neoplasms

,

colonic neoplasms

,

rectal neoplasms

,

diabetes mellitus

,

squamous cell carcinoma

,

squamous cell neoplasms

,

,

cardiovascular diseases

,

hyperlipidemias

,

,

atherosclerosis

,

aplastic anemia

,

mucocutaneous lymph node syndrome

,

non-hodgkin lymphoma

,

multiple myeloma

,

renal cell carcinoma

,

stomach neoplasms

,

lupus nephritis

,

,

hepatic encephalopathy

,

,

hematologic neoplasms

,

,

,

head and neck neoplasms

,

metabolic bone diseases

,

,

postmenopausal osteoporosis

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

erectile dysfunction

,

,

precursor cell lymphoblastic leukemia-lymphoma

alzheimer disease

,

memory disorders

,

cognitive dysfunction

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use